Total raised
—
Last: Seed 2016-10
Stage
Seed
Founded
2011
Headcount
6
HQ
Ramat Gan
Sector
Health Tech & Life Sciences
About
I2O Pharma specializes in developing oral versions of injectable drugs, using technology licensed from the Hebrew University of Jerusalem. The company is now planning human trials. I2O Pharma is supported byAurum Ventures MKI. The company is inactive and the updating process will be stopped since 11/2018.
Funding history · 1 round · — total
2016-10
Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is I2O Pharma's primary focus?
- I2O Pharma specializes in developing oral versions of injectable drugs, utilizing technology licensed from the Hebrew University of Jerusalem.
- When was I2O Pharma founded?
- I2O Pharma was founded in December 2011.
- What is the current operational status of I2O Pharma?
- I2O Pharma is currently inactive, with its status marked as 'Non Active' since January 2018. According to startupim data, the updating process for the company stopped in November 2018.
- Which investor supported I2O Pharma?
- I2O Pharma was supported by Aurum Ventures M.K.I.
- What was I2O Pharma's last known funding round?
- I2O Pharma secured a Seed round in October 2016, with Aurum Ventures M.K.I. as an investor.
- What is I2O Pharma's current product development stage?
- I2O Pharma's product is in the clinical trial stage, with plans for human trials.
- How many employees did I2O Pharma have?
- I2O Pharma had 6 employees.
- Where is I2O Pharma headquartered?
- I2O Pharma is headquartered in Ramat Gan, Israel.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalsdrug-deliveryoral-drugspharma-companies